We are live on ! Find out more
RHBC

R.H. Bluestein & Co Portfolio holdings

AUM $1.61B
1-Year Est. Return 7.59%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
-7.59%
3 Year Est. Return
+69.02%
5 Year Est. Return
+139.59%
10 Year Est. Return
–
AUM
$1.67B
AUM Growth
+$135M
Cap. Flow
+$22.1M
Cap. Flow %
1.32%
Top 10 Hldgs %
32.92%
Holding
336
New
30
Increased
77
Reduced
81
Closed
11

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$18.9M
2
STI
SunTrust Banks, Inc.
STI
+$17M
3
APTV icon
Aptiv
APTV
+$15.8M
4
INTC icon
Intel
INTC
+$13.5M
5
CRM icon
Salesforce
CRM
+$12.6M

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$27.3M
2
BMY icon
Bristol-Myers Squibb
BMY
+$24.2M
3
PANW icon
Palo Alto Networks
PANW
+$23.4M
4
XOM icon
ExxonMobil
XOM
+$17.1M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Industrials 18.82%
2 Communication Services 14.56%
3 Healthcare 11.18%
4 Technology 10.25%
5 Consumer Discretionary 9.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TS icon
301
Tenaris
TS
$28.6B
$205K 0.01%
6,000
– –
WIT icon
302
Wipro
WIT
$19.3B
$205K 0.01%
106,667
– –
PCAR icon
303
PACCAR
PCAR
$70.4B
$202K 0.01%
+4,500
New +$203K
KN icon
304
Knowles
KN
$3.08B
$190K 0.01%
10,000
– –
WLL
305
DELISTED
Whiting Petroleum Corporation
WLL
$189K 0.01%
67
– –
DCH
306
Dauch Corp
DCH
$1.39B
$188K 0.01%
10,000
– –
BCS icon
307
Barclays
BCS
$93.4B
$175K 0.01%
16,357
-142
-0.9% -$1.53K
HBAN icon
308
Huntington Bancshares
HBAN
$34.5B
$166K 0.01%
+12,400
New +$169K
CVA
309
DELISTED
Covanta Holding Corporation
CVA
$157K 0.01%
10,000
– –
BRFS
310
DELISTED
BRF SA
BRFS
$147K 0.01%
12,000
– –
AMD icon
311
Advanced Micro Devices
AMD
$791B
$146K 0.01%
+10,000
New +$127K
BKD icon
312
Brookdale Senior Living
BKD
$3.49B
$134K 0.01%
10,000
– –
DDC
313
DELISTED
Dominion Diamond Corporation
DDC
$126K 0.01%
10,000
– –
MWA icon
314
Mueller Water Products
MWA
$3.9B
$118K 0.01%
+10,000
New +$127K
RT
315
DELISTED
Ruby Tuesday Georgia
RT
$118K 0.01%
42,000
-50,000
-54% -$109K
CCJ icon
316
Cameco
CCJ
$38.4B
$111K 0.01%
10,000
– –
PLUG icon
317
Plug Power
PLUG
$2.92B
$104K 0.01%
75,000
– –
TCRT icon
318
Alaunos Therapeutics
TCRT
$4.59M
$76K ﹤0.01%
80
– –
TTNP
319
DELISTED
Titan Pharmaceuticals
TTNP
$73K ﹤0.01%
6
– –
CHK
320
DELISTED
Chesapeake Energy Corporation
CHK
$68K ﹤0.01%
58
– –
VUZI icon
321
Vuzix
VUZI
$194M
$62K ﹤0.01%
10,000
– –
VVUS
322
DELISTED
Vivus Inc
VVUS
$11K ﹤0.01%
1,000
– –
SUNE
323
DELISTED
SUNEDISON, INC COM
SUNE
$1K ﹤0.01%
12,000
– –
BMY icon
324
Bristol-Myers Squibb
BMY
$132B
– –
-413,877
Closed -$24.2M
BXP icon
325
Boston Properties
BXP
$11.4B
– –
-2,300
Closed -$289K
10 11 12
13
14

Similar funds

BDF
Balasa Dinverno & Foltz $1.58B AUM 17.55% 1-Year Est. Return
ACM
AlphaCrest Capital Management New York $1.64B AUM 23.4% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
WFA
Wipfli Financial Advisors Milwaukee, Wisconsin $1.42B AUM 20.63% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
CA
Capitolis Advisors New York $1.41B AUM 17.33% 1-Year Est. Return
RIG
Roosevelt Investment Group New York $1.39B AUM 5.42% 1-Year Est. Return
CCP
Corient Capital Partners Newport Beach, California $1.34B AUM 12.46% 1-Year Est. Return

R.H. Bluestein & Co's Q1 2017 Portfolio in Review

As of Q1 2017, R.H. Bluestein & Co held 336 positions worth $1.67B, up 8.8% from $1.53B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

R.H. Bluestein & Co's Q1 2017 filing shows 30 new, 77 increased, 81 reduced and 11 closed positions. Its largest new stake was SunTrust Banks, Inc.: 296,401 shares worth $16.4M. The largest sale was Monsanto Co, an estimated $27.3M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 21% a quarter earlier, followed by Communication Services and Healthcare.

  • R.H. Bluestein & Co's largest Q1 2017 buy was SunTrust Banks, Inc.: 296,401 shares worth $16.4M.
  • R.H. Bluestein & Co added most to Microsoft in Q1 2017, an estimated $18.9M increase.
  • R.H. Bluestein & Co's biggest Q1 2017 reduction was Monsanto Co, cutting an estimated $27.3M.
  • R.H. Bluestein & Co fully exited Bristol-Myers Squibb in Q1 2017, selling an estimated $24.2M.
  • R.H. Bluestein & Co's ten largest holdings make up 33% of its $1.67B portfolio in Q1 2017.
  • R.H. Bluestein & Co opened 30 new positions and closed 11 in Q1 2017.
  • R.H. Bluestein & Co's portfolio value rose 8.8% quarter-over-quarter to $1.67B.

Based on R.H. Bluestein & Co's 13F filing for Q1 2017, filed 12 May 2017.